Cyprotex
Acquired by Evotec
Is this your company?
Cyprotex Snapshot
Our Mission Statement
• To exceed our customers' expectations in the provision of our services
• To maintain our position as the leading ADME-Tox outsourced service provider to the pharmaceutical and chemical industries
• To focus on our core deliverables of high quality data at the most cost-effective price to our customers
• To expand our customer base and deepen the relationships with our existing clients
• To invest in R&D to introduce and further develop unique, cutting edge solutions and services
• To share our knowledge and expertise within the industry
• To improve the recognition of the Cyprotex brand worldwide
Careers
As a fast-growing life science company, we offer you a wide range of career opportunities.
With us, you'll take on challenges and can realize the full breadth of your potential as part of a diverse team working across the globe. The joy of exploring is a feeling that unites us all. Together, we are CUREious.
• To exceed our customers' expectations in the provision of our services
• To maintain our position as the leading ADME-Tox outsourced service provider to the pharmaceutical and chemical industries
• To focus on our core deliverables of high quality data at the most cost-effective price to our customers
• To expand our customer base and deepen the relationships with our existing clients
• To invest in R&D to introduce and further develop unique, cutting edge solutions and services
• To share our knowledge and expertise within the industry
• To improve the recognition of the Cyprotex brand worldwide
Careers
As a fast-growing life science company, we offer you a wide range of career opportunities.
With us, you'll take on challenges and can realize the full breadth of your potential as part of a diverse team working across the globe. The joy of exploring is a feeling that unites us all. Together, we are CUREious.
Who We are
Cyprotex’s vision is to enable and enhance the prediction of human exposure, clinical efficacy and toxicological outcome of a drug or chemical. By combining quality data from robust in vitro methods with contemporary in silico technology, we add value, context and relevance to the ADME-Tox data supplied to our customers in the pharmaceutical or chemical industries.
In 2016, Cyprotex was acquired by Evotec (www.evotec.com).
Cyprotex’s vision is to enable and enhance the prediction of human exposure, clinical efficacy and toxicological outcome of a drug or chemical. By combining quality data from robust in vitro methods with contemporary in silico technology, we add value, context and relevance to the ADME-Tox data supplied to our customers in the pharmaceutical or chemical industries.
In 2016, Cyprotex was acquired by Evotec (www.evotec.com).
